Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-054436

Director acquired 20,804 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Postma Robert W Director 2025-04-13 Grant or award +20,804 $2.92 $60,748 29,083 D
Derivatives
Postma Robert W Director 2025-04-11 Purchase · Series A-1 Convertible Preferred Stock +500 $2.76 $1,380 500 I
Loading xslF345X05/ownership.xml…